Atherosclerosis, the underlying cause of cardiovascular disease (CVD), is a worldwide
cause of morbidity and mortality. Reducing ApoB-containing lipoproteins—chiefly, LDL (low …

Oxidized LDL (oxLDL) and nitric oxide (NO) exert contradictory actions within the vascular
endothelium microenvironment influencing key events in atherogenesis. OxLDL and NO are …

Risk for atherosclerotic cardiovascular disease (ASCVD) shows considerable heterogeneity
both in generally healthy persons and in those with known ASCVD. The foundation of …

The mannose receptor is a member of the C-type lectin (CLEC) family, which can bind and
internalize a variety of endogenous and pathogen-associated ligands. Because of these …

Background When the lectinlike oxidized low‐density lipoprotein (ox LDL) receptor‐1 (LOX‐
1), a scavenger receptor for ox LDL, binds ox LDL, processes leading to endothelial …

Cardiovascular diseases are the leading cause of death worldwide. Approximately 85% of
all deaths from cardiovascular disease are due to acute myocardial infarction (AMI) and …

Background Blockade of the lectin‐like oxidized low‐density lipoprotein receptor‐1 (LOX‐1)
is a potentially attractive mechanism for lowering inflammatory and lipid risk in patients with …

Lectin‐like oxidized low density lipoprotein receptor‐1 (LOX‐1), the main oxidized low‐
density lipoprotein (OxLDL) in endothelial cells, is upregulated in atherosclerotic lesions and …

Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), a scavenger receptor of
oxidized low-density lipoprotein (ox-LDL) found in various cells, plays a crucial role in the …

Background Soluble lectin‐like oxidized low‐density lipoprotein receptor‐1 (sLOX‐1) has
been shown to be increased in patients with acute ischemic stroke. Here, we evaluated …